Obesity and Pulmonary Hypertension: A Review of Pathophysiologic Mechanisms
Author(s) -
Scott Friedman,
Bruce W. Andrus
Publication year - 2012
Publication title -
journal of obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 53
eISSN - 2090-0716
pISSN - 2090-0708
DOI - 10.1155/2012/505274
Subject(s) - medicine , obesity , obesity hypoventilation syndrome , pulmonary hypertension , pathophysiology , obstructive sleep apnea , hyperuricemia , disease , intensive care medicine , cardiology , cardiomyopathy , endothelial dysfunction , heart failure , bioinformatics , uric acid , biology
Pulmonary hypertension (PH) is a potentially life-threatening condition arising from a wide variety of pathophysiologic mechanisms. Effective treatment requires a systematic diagnostic approach to identify all reversible mechanisms. Many of these mechanisms are relevant to those afflicted with obesity. The unique mechanisms of PH in the obese include obstructive sleep apnea, obesity hypoventilation syndrome, anorexigen use, cardiomyopathy of obesity, and pulmonary thromboembolic disease. Novel mechanisms of PH in the obese include endothelial dysfunction and hyperuricemia. A wide range of effective therapies exist to mitigate the disability of PH in the obese
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom